These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 25241269)

  • 1. Quality indicators on the use of antimicrobials in critically ill patients.
    Vera P; Palomar M; Álvarez-Lerma F
    Med Intensiva; 2014 Dec; 38(9):567-74. PubMed ID: 25241269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug utilisation in adult, paediatric and neonatal intensive care units, with an emphasis on systemic antimicrobials.
    Sridharan K; Hasan H; Al Jufairi M; Al Daylami A; Abdul Azeez Pasha S; Al Ansari E
    Anaesthesiol Intensive Ther; 2021; 53(1):18-24. PubMed ID: 33625820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Selection of indicators for continuous monitoring of the impact of programs optimizing antimicrobial use in Primary Care].
    Fernández-Urrusuno R; Flores-Dorado M; Moreno-Campoy E; Montero-Balosa MC
    Enferm Infecc Microbiol Clin; 2015 May; 33(5):311-9. PubMed ID: 25444046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial drug interactions in the critically ill patients.
    Pereira JM; Paiva JA
    Curr Clin Pharmacol; 2013 Feb; 8(1):25-38. PubMed ID: 22946870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of antimicrobial use in the intensive care unit.
    Alvarez-Lerma F; Palomar M; Grau S
    Drugs; 2001; 61(6):763-75. PubMed ID: 11398908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Point prevalence survey of antimicrobial utilization in the cardiac and pediatric critical care unit.
    Blinova E; Lau E; Bitnun A; Cox P; Schwartz S; Atenafu E; Yau Y; Streitenberger L; Parshuram CS; Marshall J; Seto W
    Pediatr Crit Care Med; 2013 Jul; 14(6):e280-8. PubMed ID: 23823209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antimicrobial therapy of severe infections in critically ill patients].
    Rybicki Z; Tomaszewski D
    Pol Merkur Lekarski; 2011 May; 30(179):338-41. PubMed ID: 21675137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the defined daily dose and days of treatment methods for evaluating the consumption of antibiotics and antifungals in the intensive care unit.
    Vallès J; Fernández S; Cortés E; Morón A; Fondevilla E; Oliva JC; Diaz E
    Med Intensiva (Engl Ed); 2020; 44(5):294-300. PubMed ID: 31378384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and economic impact of clinical pharmacist interventions regarding antimicrobials on critically ill patients.
    Leache L; Aquerreta I; Aldaz A; Monedero P; Idoate A; Ortega A
    Res Social Adm Pharm; 2020 Sep; 16(9):1285-1289. PubMed ID: 31327737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial de-escalation in critically ill patients: a position statement from a task force of the European Society of Intensive Care Medicine (ESICM) and European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Critically Ill Patients Study Group (ESGCIP).
    Tabah A; Bassetti M; Kollef MH; Zahar JR; Paiva JA; Timsit JF; Roberts JA; Schouten J; Giamarellou H; Rello J; De Waele J; Shorr AF; Leone M; Poulakou G; Depuydt P; Garnacho-Montero J
    Intensive Care Med; 2020 Feb; 46(2):245-265. PubMed ID: 31781835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and pharmacodynamics of antimicrobial drugs in intensive care unit patients.
    Macedo RS; Onita JH; Wille MP; Furtado GH
    Shock; 2013 May; 39 Suppl 1():24-8. PubMed ID: 23481498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of obesity on the pharmacokinetics of antimicrobials in critically ill patients: A structured review.
    Alobaid AS; Hites M; Lipman J; Taccone FS; Roberts JA
    Int J Antimicrob Agents; 2016 Apr; 47(4):259-68. PubMed ID: 26988339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of antimicrobial use pattern in the intensive treatment unit of a teaching hospital in western Nepal.
    Shankar PR; Partha P; Shenoy N; Brahmadathan KN
    Am J Infect Control; 2003 Nov; 31(7):410-4. PubMed ID: 14639438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial use in the ICU: indications and accuracy--an observational trial.
    Levin PD; Idrees S; Sprung CL; Weissman C; Weiss Y; Moses AE; Benenson S
    J Hosp Med; 2012; 7(9):672-8. PubMed ID: 22865497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bench-to-bedside review: antimicrobial utilization strategies aimed at preventing the emergence of bacterial resistance in the intensive care unit.
    Kollef MH
    Crit Care; 2005 Oct; 9(5):459-64. PubMed ID: 16277734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical indications treated with unregistered antimicrobials: regulatory challenges of antimicrobial resistance and access to effective treatment for patients.
    Hillock NT; Paradiso L; Turnidge J; Karnon J; Merlin TL
    Aust Health Rev; 2020 Apr; 44(2):263-269. PubMed ID: 31272525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Changes observed in three quality indicators after the implementation of improvement strategies in the respiratory intensive care unit].
    Álvarez Maldonado P; Cueto Robledo G; Cicero Sabido R
    Med Intensiva; 2015 Apr; 39(3):142-8. PubMed ID: 24661920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Worldwide Antibiotic Resistance and Prescribing in European Children (ARPEC) point prevalence survey: developing hospital-quality indicators of antibiotic prescribing for children.
    Versporten A; Bielicki J; Drapier N; Sharland M; Goossens H;
    J Antimicrob Chemother; 2016 Apr; 71(4):1106-17. PubMed ID: 26747104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality indicators for end-of-life care in the intensive care unit.
    Clarke EB; Curtis JR; Luce JM; Levy M; Danis M; Nelson J; Solomon MZ;
    Crit Care Med; 2003 Sep; 31(9):2255-62. PubMed ID: 14501954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using simulation to isolate physician variation in intensive care unit admission decision making for critically ill elders with end-stage cancer: a pilot feasibility study.
    Barnato AE; Hsu HE; Bryce CL; Lave JR; Emlet LL; Angus DC; Arnold RM
    Crit Care Med; 2008 Dec; 36(12):3156-63. PubMed ID: 18936694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.